Wednesday

17th Jan 2018

Merck stops cancer drug supply to Greek hospitals

  • The pharmaceutical industry says it has contributed billions to crisis-hit EU countries (Photo: www.freeimages.co.uk)

German drug company Merck has halted life-saving cancer drug shipments to Greek public hospitals.

Its chief financial officer, Matthias Zachert told German paper Boersen-Zeitung on Saturday (3 November) that the crisis-struck country has not paid its bills.

Thank you for reading EUobserver!

Subscribe now for a 30 day free trial.

  1. €150 per year
  2. or €15 per month
  3. Cancel anytime

EUobserver is an independent, not-for-profit news organization that publishes daily news reports, analysis, and investigations from Brussels and the EU member states. We are an indispensable news source for anyone who wants to know what is going on in the EU.

We are mainly funded by advertising and subscription revenues. As advertising revenues are falling fast, we depend on subscription revenues to support our journalism.

For group, corporate or student subscriptions, please contact us. See also our full Terms of Use.

If you already have an account click here to login.

"It only affects Greece, where we have been faced with many problems. It's just the one product," he said.

Reuters reports that the cancer-fighting drug is called Erbitux. While the medication will no longer be available at public hospitals, Greeks can still purchase it directly from pharmacies.

The drug fights colorectal cancer and head and neck cancer and is Merck's second best-selling product. In 2011, it generated some €855 million in profits.

The Merck Group reported total revenue €2.8 billion in the second quarter of 2012, an 11.6 percent increase on quarter two last year.

An report in August by GlobalData, a market intelligence analysis group, said that pharmacies in Greece have dropped prices so that cash-strapped citizens can pay for them.

It added that the cheaper drugs have created a "lucrative export carry trade" for Greeks re-selling them over the border.

For its part, the European Federation of Pharmaceutical Industries (Efpia), a Brussels-based trade body, on Sunday sent a letter to the Greek government with a plan to maintain drug supplies in light of its near-empty state coffers.

Efpia's text - seen by Reuters - says international drug companies would be willing to ship supplies to Greece if the government caps outpatient pharmaceutical expenditure at €2.9 billion in 2012.

The news agency says Efpia wants the Greek government to pay off its overdue bills and maintain a balanced sheet.

"Setting a growth cap or budget ceiling is not something we have ever liked to do in the past, but in the current environment it is better to do that and have some stability," Richard Bergstrom, Efpia's director general, told Reuters.

Efpia says Europe's pharmaceutical industry has contributed some €7 billion in the form of rebates and discounts between 2010 and 2011 to Greece, Ireland, Italy, Portugal and Spain.

The figure represents around 8 percent of the industry's annual turnover in those markets.

Focus

Power to the patient

Doctors, it is said, are not what can be called early adopters of new technologies. Any healthcare revolution, then, will have to come through patients. Or rather, consumers, because patients of the 21st century make their own decisions.

EU posted workers face hurdles

Negotiations among the EU institutions will start soon, but could be difficult on several issues - like the inclusion of the transport sector or the duration of a posting.

EU overcomes divisions on posted workers

After a 12-hour discussion, EU employment ministers struck a compromise to reform the rules on workers posted in another country. The principle of equal pay for equal work has been adopted but the transport sector will get special treatment.

Opinion

EU's 'old men' must pressure Poland on abortion rights

Despite fresh crackdowns on Poland's already restrictive abortion laws, EU commission president Juncker did not raise the issue with the new Polish PM Morawiecki - perhaps because it was an all-male event?

Stakeholders' Highlights

  1. AJC Transatlantic InstituteAJC Calls on EU to Sanction Iran’s Revolutionary Guards, Expel Ambassadors
  2. Dialogue PlatformRoundtable on "Political Islam, Civil Islam and The West" 31 January
  3. ILGA EuropeFreedom of Movement and Same-Sex Couples in Romania – Case Update!
  4. EU2017EEEstonia Completes First EU Presidency, Introduced New Topics to the Agenda
  5. Bio-Based IndustriesLeading the Transition Towards a Post-Petroleum Society
  6. ACCAWelcomes the Start of the New Bulgarian Presidency
  7. Mission of China to the EUPremier Li and President Tusk Stress Importance of Ties at ASEM Summit
  8. EU2017EEVAT on Electronic Commerce: New Rules Adopted
  9. European Jewish CongressChair of EU Parliament Working Group on Antisemitism Condemns Wave of Attacks
  10. Counter BalanceA New Study Challenges the Infrastructure Mega Corridors Agenda
  11. Dialogue PlatformThe Gülen Community: Who to Believe - Politicians or Actions?" by Thomas Michel
  12. Plastics Recyclers Europe65% Plastics Recycling Rate Attainable by 2025 New Study Shows